HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Mitoguazone (MGBG)

Antineoplastic agent effective against myelogenous leukemia in experimental animals. Also acts as an inhibitor of animal S-adenosylmethionine decarboxylase.
Also Known As:
MGBG; Methyl-gag; NSC-32946; Methyl gag; Methylgag; NSC 32946; NSC32946; Methylglyoxal Bis(guanylhydrazone); Hydrazinecarboximidamide, 2,2'-(1-methyl-1,2-ethanediylidene)bis-
Networked: 220 relevant articles (9 outcomes, 63 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Hou, Ming-Hon: 2 articles (01/2012 - 06/2009)
2. Yuann, Jeu-Ming P: 2 articles (01/2012 - 06/2009)
3. Liu, Hong: 2 articles (04/2003 - 01/2003)
4. Chen, Wei R: 2 articles (04/2003 - 01/2003)
5. Ishmael, D Richard: 2 articles (04/2003 - 01/2003)
6. Nordquist, Robert E: 2 articles (04/2003 - 01/2003)
7. Samoylenko, O: 1 article (12/2015)
8. Karnaushenko, O V: 1 article (12/2015)
9. Gulua, L: 1 article (12/2015)
10. Turmanidze, T: 1 article (12/2015)

Related Diseases

1. Neoplasms (Cancer)
2. Leukemia
3. Adenocarcinoma
4. Psoriasis (Pustulosis Palmaris et Plantaris)
5. Lymphoma (Lymphomas)

Related Drugs and Biologics

1. Mitoguazone (MGBG)
2. Eflornithine (Ornidyl)
3. Spermidine
4. Spermine
5. Fluorouracil (Carac)
6. Cisplatin (Platino)
7. Vinblastine (Vinblastine Sulfate)
8. Etoposide (VP 16)
9. Ifosfamide
10. Methotrexate (Mexate)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Combination Drug Therapy (Combination Chemotherapy)
3. Esophagectomy
4. Transplantation (Transplant Recipients)
5. Salvage Therapy